Close
Smartlab Europe
Achema middle east

Drug Research

Patient Groups Rejoice As Pharma Dismisses Drug Pricing Law

The pharmaceutical lobbying group's aura of invincibility has faded. The U.S. Senate recently passed a new bill, leaving the pharmaceutical sector licking its wounds and paving the way for a significant drug pricing overhaul. If the comprehensive climate and tax...

Why Children Are Better Protected From COVID-19 And More

There were a lot of mysteries surrounding COVID-19, some of which have been answered, but many more have not. Since the start of the pandemic, it has been a mystery as to why children appear to be considerably less...

Pharmacopoeias To Aid Vaccine Creation And Research Further

The mRNAVAC Working Party was established by the European Pharmacopoeia Commission to start developing standards of quality to support the developing area of messenger RNA (mRNA) vaccines. The first job for the newly formed Working Party will be to produce...

AstraZeneca’s Enhertu wins keenly-anticipated U.S. breast cancer nod

AstraZeneca (AZN.L) and Daiichi Sankyo (4568.T) on Friday secured U.S. approval that broadens the use of their therapy Enhertu, for patients with breast cancer, and paves the way for billions in sales. This is the first-ever U.S. Food and Drug Administration (FDA) approval for...

GenKOre- Korea Creating Base-Editing Tech For Genetic Issues

Adenine base editors were successfully created by GenKOre, a biotech startup in South Korea, using its unique hypercompact gene-editing method. The hypercompact ABEs created by GenKOre are distinguished by their small size, ability to be delivered via an adeno-associated virus...

NICE Has Granted Its Endorsement To Beovu From Novartis

Following NICE's recommendation of a novel therapy alternative for diabetic macular oedema (DMO), thousands of patients could receive transformative care. In the final form of the guidance, brolucizumab, also known as Beovu, is suggested as a treatment for adults...

Lilly, AZ, AbbVie, J&J May Be Hit By Medicare Pricing Bill

Could the Senate adopt a "watershed" bill allowing drug price discussions after years of government inaction regarding medication prices in the U.S.? Analysts are busy studying the information at hand to determine how the legislation would impact the leading companies...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »